Apogee Therapeutics, Inc. (APGE)
Healthcare
Biotechnology
134.10 $
-0.2%
vs. previous close
Closing price · As of: 31. Jul 2026
Apogee Therapeutics, Inc. (APGE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -56 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -15 | -20 | -30 | -32 | -29 | -43 | -68 | -48 | -62 | -54 | -63 | -56 | -235 | |
| 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | 0.4 | 0.4 | 0.4 | 0.4 | 1.6 | |
| 1.1 | 1.5 | 2.2 | 4.2 | 5.7 | 5.8 | 7.6 | 11 | 11 | 12 | 12 | 17 | 52 | |
| 1.1 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 3.2 | -0.3 | 2.5 | -1.3 | 1.5 | 3.7 | -6.0 | -2.9 | -6.8 | -0.8 | -4.9 | 1.5 | -11 | |
| 0.0 | 0.0 | 0.2 | 0.4 | 0.1 | 0.8 | 0.0 | 4.3 | 0.8 | 0.0 | 0.1 | 0.0 | 0.8 | |
| – | -234 | -274 | -52 | -149 | -146 | 46 | 13 | 78 | 18 | -289 | -35 | -228 | |
| – | – | 0.0 | – | – | – | – | – | – | – | – | – | – | |
| -1.7 | 317 | -0.2 | 451 | -0.2 | 0.4 | 44 | 0.6 | 1.2 | 20 | 375 | 411 | 807 | |
| -16 | 63 | -70 | 367 | -178 | -189 | 23 | -35 | 17 | -17 | 24 | 320 | 345 | |
| -15 | -20 | -30 | -32 | -29 | -43 | -68 | -53 | -63 | -54 | -63 | -56 | -235 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.